Research
Hormonal
Preoperative glycemic control using synthetic oral hypoglycemic drugs significantly reduces the risk of T2D recurrence after bariatric surgery.
If you are having bariatric surgery, work with your doctor to get your blood sugar under control with oral medications before the procedure. Good pre-surgical control is linked to a lower chance of your diabetes coming back after surgery.
ModerateSupportsMEDIUM confidence
Preoperative glucose control by oral hypoglycemic drugs reduces the chance of T2D recurrence post-surgery
Why this rating
Based on observational data and clinical correlations cited in the text.
Source
Synthetic agents in the context of metabolic/bariatric surgery: expanding the scope and impact of diabetes drug discovery
David R. Janero · Expert Opinion on Drug Discovery · 2014
DOI 10.1517/17460441.2014.876988
narrative_reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Bariatric surgery is not a guaranteed cure for type 2 diabetes, with significant rates of non-remission (20-40%) and recurrence (up to 50% at 10 years) occurring even after successful weight loss.Good
- GLP-1 receptor agonists may enhance the weight loss and metabolic benefits of adjustable gastric banding (AGB) by mimicking the hormonal effects of more invasive surgeries like Roux-en-Y gastric bypass.Limited
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →